Drug Channels

MAY 22, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. We use Zoom technology for this webinar.

Pharmacy 97

Pharmacy Drugs Marketing Therapies 97

Drug Channels

SEPTEMBER 14, 2021

On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. This report—our twelfth edition— remains the most comprehensive, fact-based tool for understanding and analyzing the large and growing U.S. to 1:30 p.m.

Pharmaceuticals 94

Pharmaceuticals Drugs Marketing 94

BioPharma Drive: Drug Pricing

JUNE 23, 2025

The black and gray market risks Ben warned about the proliferation of counterfeit GLP-1 drugs in unregulated markets, posing significant dangers to patients who might unknowingly use ineffective or harmful products. The balance is complex, as obesity carries its own serious health risks.

Treatment 130

Treatment Drugs Therapies FDA 130

Fierce BioTech

FEBRUARY 12, 2025

Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement. Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement. Register now to secure your spot.

Regulations 52

Regulations Marketing Compliance Production 52

Fierce BioTech

AUGUST 7, 2024

The Unfiltered Truth about AI & Pharma Marketing dwunderlin Wed, 08/07/2024 - 12:04 Wed, 09/04/2024 - 14:00 Resource Type Webinar Chris Cullmann Doug Barr Promotion Start Thu, 08/08/2024 - 15:00 Promotion End Sat, 02/08/2025 - 15:00 Duration 60 Minutes You need to know where artificial intelligence disrupts the pharmaceutical marketing norms.

Marketing 52

Marketing Pharmaceutical Companies Pharmaceuticals Production 52

Fierce BioTech

APRIL 4, 2025

The integration of AI-powered market intelligence offers pharmaceutical companies a competitive edge by enabling real-time insights, predictive analytics, and strategic decision-making. Join us to gain valuable insights into how pharmaceutical companies can leverage AI to achieve more with less.

Marketing 52

Marketing Pharmaceutical Companies Pharmaceuticals 52

Drug Channels

OCTOBER 5, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. During the full 90-minute webinar, I discussed seven crucial risks that could disrupt this market along with many other aspects of this emerging market.

Pharmaceuticals 97

Pharmaceuticals Marketing Drugs 97

Drug Channels

SEPTEMBER 9, 2021

In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. drug purchaser. to 1:30 p.m.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs Pharmacy 98

Fierce BioTech

MAY 7, 2024

Trust Transformed: Pharma Marketing in the Post-Cookie Era dwunderlin Tue, 05/07/2024 - 13:29 Tue, 06/11/2024 - 14:00 Resource Type Webinar David Minkin Clifton Covey Sonia V Gupta Duration 60 Minutes In the backdrop of digital advertising for pharmaceuticals we are undergoing a radical transformation as privacy becomes a paramount concern.

Marketing 52

Marketing Compliance Pharmaceuticals 52

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Drug Channels

JULY 29, 2022

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. healthcare spending. healthcare spending.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Fierce BioTech

JANUARY 24, 2025

Patient Content Marketing 2.0: As AI matures, it offers a transformative toolkit for pharma marketers to not only ideate and produce content efficiently but also deliver it with precision to the right patient at the right time. How generative AI is shaping the creative process, enabling marketers to rapidly ideate and build campaigns.

Marketing 52

Marketing Pharmaceuticals 52

Alta Sciences

FEBRUARY 8, 2024

In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G. Various psychomotor and neuropsychological tests, including the measurement of reaction time, divided attention, selective attention, and memory, may still be appropriate.

Clinical Trials 52

Clinical Trials Trials Clinical Pharmacology Clinical Development 52

Drug Channels

APRIL 12, 2022

What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. One bright spot: consumers will account for an ever-smaller share of drug spending. healthcare spending growth. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Fierce BioTech

MAY 22, 2024

So, how can pharmaceutical and biotech companies enter this market, and how can EAPs support and facilitate future successful commercialization? This webinar will delve into the benefits of Expanded Access Programs in Europe. Click here to login. Listing Image Sciensus_ListingLogo_250x190.png

Marketing 52

Marketing Regulations Pharmaceuticals Treatment 52

The Pharma Data

SEPTEMBER 15, 2020

Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk. In this webinar you will: Master how to optimize supply planning and distribution by using supply forecasting and IRT. 7am PDT.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Today, I examine these PBM-owned GPOs and then speculate on five plausible explanations for their existence. to 1:30 p.m.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

OCTOBER 2, 2024

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The 340B contract pharmacy market shows little sign of slowing down. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Fierce BioTech

OCTOBER 17, 2024

This webinar will feature industry leaders discussing how to deepen insights into patient behaviors while safeguarding privacy. They’ll explore the benefits of a holistic, patient-centered strategy that embraces diverse patient needs, driving more timely treatments and maximizing the impact of marketing efforts. Click here to login.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Marketing 52

Fierce BioTech

APRIL 3, 2025

Roadmap to Product Launch and Commercialization in Europe pesurya Thu, 04/03/2025 - 10:38 Wed, 05/21/2025 - 11:00 Resource Type Webinar Marie-Charlotte von Brevern Eva Keck Chris Englerth Europe presents a dynamic and growing market for U.S. companies seeking to expand their reach and to bring innovative treatments to patients.

Production 52

Production Marketing Treatment Pharmaceuticals 52

Fierce BioTech

DECEMBER 27, 2023

This webinar will explore innovative Direct-to-Patient cash solutions as a way to improve accessibility, convenience, and patient outcomes. Don't miss this opportunity to learn how pharma organizations can retain market share, increase overall profitability and boost their brand's gross to net. Click here to login.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmacy Therapies Pharmaceuticals 52

PPD

SEPTEMBER 16, 2024

The pharmaceutical industry is currently experiencing a significant transformation. Our comprehensive approach, integrating various aspects of drug development, such as clinical development, post-approval activities and market access, ensures optimal utilization of tools and strategies.

Clinical Development 98

Clinical Development Clinical Trials Clinical Research Drug Development 98

The Connected Lab

JUNE 2, 2021

Exploring how digital transformation will revolutionize process optimization and decision-making within the pharmaceutical industry Networked digital technologies and advanced automation are transforming pharmaceutical manufacturing , enabling efficiencies through real-time process optimization and faster decision-making.

Pharmaceuticals 52

Pharmaceuticals Laboratories Pharmaceutical Companies Production 52

Fierce BioTech

JANUARY 12, 2024

Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.

Drugs 52

Drugs Packaging Compliance Drug Development 52

Drug Channels

MARCH 26, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. I shared my $0.02

Pharmacy 52

Pharmacy Hospitals Pharmaceuticals Drugs 52

The Pharma Data

NOVEMBER 16, 2020

We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. Add bookmark. Download Your Copy. You have the right to object. Download Your Copy.

Science 52

Science Production Pharmaceuticals Marketing 52

Elrig

APRIL 7, 2025

In this role, he will lead ELRIGs mission to foster collaboration, innovation, and knowledge-sharing through scientific conferences, networking events, webinars, and digital content. Dr Trezise succeeds Melanie Leveridge, who successfully completed her four-year term as Chair.

Assay Development 59

Assay Development Laboratories Science Drugs 59

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. That’s about six times faster than the overall mail and specialty market. Consequently, specialty pharmacies have gained a greater share of the 340B market.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Marketing Pharmaceuticals 40

The Pharma Data

AUGUST 21, 2020

As the pharma community continue to research and develop hundreds of potential therapies to combat the Covid-19 pandemic, very few initiatives are yet to cross the finishing line into the commercial market. REGN -COV2 could be a critical line of defense against the Covid-19 pandemic.”. Sign up now.

Vaccine 52

Vaccine Pharmacy Clinical Trials Virus 52

Drug Channels

MARCH 18, 2025

Pharmacies and PBMs, Examining $683 Billion Market Review pricing/license options and download the full 2025 report Order before March 31, 2025 to receive special discounted pricing! Want to bundle the report with DCIs video webinars ? drug pricing, reimbursement, and dispensing system. Email Paula Fein ( paula@drugchannels.net ).

Pharmacy 52

Pharmacy Specialty Pharmacies Licensing Licensing 52

Elrig

SEPTEMBER 14, 2023

ELRIG aims to bring the life science and drug discovery communities together to learn, share, connect, innovate, and collaborate, on an open-access basis through the provision of conferences, networking events, webinars, and digital content.

Science 59

Science Marketing Laboratories Research 59

The Pharma Data

NOVEMBER 27, 2020

One dose of the Sputnik V vaccine will cost less than $10 for international markets. The Russian Direct Investment Fund (RDIF) has announced the cost of the Russian Sputnik V vaccine for international markets will cost less than US$10 per dose and will be free of charge for all Russian citizens. Source link.

Virus 52

Virus Vaccine International Immune Response 52

H1 Blog

MAY 11, 2023

Drive Engagement and Segmentation for Physician Marketing With the proliferation of digital media, marketing in the healthcare industry has shifted from traditional tactics to an omnichannel approach. With an omnichannel approach, pharma marketers can have a better understanding of HCP interests and preferences.

Pharma Companies 52

Pharma Companies Marketing Treatment Pharmaceuticals 52

Agency IQ

MAY 3, 2024

Many of these are webinars and/or trainings sessionsfor new digital platforms. voted to adopt the compromise texts of both the revised pharmaceutical directive and regulation presented by Parliament’s health committee in March 2024. This month will also see several large, multi-day conferences hosted by public and private stakeholders.

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

Conversations in Drug Development Trends

MAY 1, 2024

The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has made strides in standardizing technical requirements to streamline pharmaceutical development on a global scale. Each nation has varying definitions of what qualifies as a pivotal study. Japan, and China. and the U.S.

Clinical Research 69

Clinical Research Trials Clinical Trials Research 69

Eye on FDA

JULY 7, 2020

In the now distant past, enforcement from this office, then called the Division of Drug Marketing, Advertising, and Communications (DDMAC) and later re-named OPDP, was robust, with the office issuing scores of letters a year (156 were issued in 1998). This item disappeared from the agenda, however, and no draft guidance was issued.

FDA 52

FDA Pharmaceutical Companies Doctors Drugs 52

The Pharma Data

JANUARY 19, 2021

CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). . – January 20, 2021) – BioHarvest Sciences Inc.

Science 40

Science Production Licensing Licensing 40